Loading organizations...
The New Jersey Health Foundation (NJHF) supports health research and early-stage companies across New Jersey. It provides diverse financial instruments, including research, innovation, community health, and education grants, along with venture funding. NJHF also offers strategic and operational management assistance, guiding researchers and nascent companies from initial concepts to market development.
Operating as a non-profit within a family of entities like The Foundation for Health Advancement, NJHF was established to foster medical and scientific progress in New Jersey. Its institutional origin reflects a broad commitment to cultivating a robust health innovation ecosystem, emphasizing a mission-driven approach, not a startup by specific individuals.
NJHF serves clinicians, researchers, and employees affiliated with partner organizations, plus early-stage health companies in New Jersey. The foundation manages endowments, distributing funds for donor-directed health research, educational programs, and scholarships. Its vision is to advance health innovations for societal benefit, facilitating ideas with potential to improve human health and patient outcomes.
New Jersey Health Foundation has 1 tracked investment across 1 company. The latest tracked deal is $5.2M Series A Extension in KayoThera in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 19, 2023 | KayoThera | $5.2M Series A Extension | Thong Le | Andy Hill Cancer Research Endowment Fund, BioAdvance, National Institutes of Health, Pier 70 Ventures, WRF Capital |